Following transmigration from the circulation into dermal and epidermal tissue, memory T cells are brought into contact with antigen-presenting dendritic and Lan-gerhanscells, aswellaswithkeratinocytes, which, probably due to genetic alterations, are also able to act as APCs. This interaction leads to the re-activation of T cells and is followed by increased production and secretion of cytokines, including IL-2, IFN-y and TNF-a, which show the TH-1 cytokine pattern typically observed in psoriasis.
• IFN-y leads to induction of ICAM-1 in keratinocy-tes and endothelium, and consequently supports binding of lymphocytes to keratinocytes. TNF- induces keratinocyte proliferation and stimulates keratinocyte-induced interleukin-8 (IL-8) production. This leads to chemotaxis of lymphocytes and neutrophils into the epidermis. TNF- is also able to induce activation and proliferation of endothelial cells.
However, the exact mechanism by which (re-)activated T cells cause psoriatic lesions is not known. Direct lym phocyte/keratinocyte interactions could be involved, or cytokines produced during T-cell re-activation may be responsible for the most prominent alteration in psoriatic skin: hyperproliferation.
In summary, a combination of different mechanisms may be responsible for the changes observed histologi-cally and clinically in psoriatic skin. These include:
• Increased proliferation of keratinocytes (hyperker-atosis)
Neutrophil and mast-cell migration into epidermis and dermis, respectively
• Increased production of defensins by activated keratinocytes
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.